MAPT and Alzheimer disease: Another study demonstrating a significant positive correlation between the elevated levels of Tau phosphorylated at Serine 396 (pS396) and Aβ1–42 in brain tissue homogenate and brain-derived EVs of AD patients supports this notion [121].